Am J Psychiatry 155:1113-1116, August 1998
©Copyright 1998 American Psychiatric Association
Novel Antipsychotics and the Neuroleptic Malignant Syndrome: A Review and Critique
Samia Hasan, M.D., and
Peter Buckley, M.D.
OBJECTIVE: The authors' goal was to analyze reported cases of neuroleptic malignant syndrome in patients given clozapine and risperidone. METHOD: They assessed 19 cases of clozapine-induced neuroleptic malignant syndrome and 13 cases of risperidone-induced neuroleptic malignant syndrome against three criteria sets and against extent of exclusionary workup and then designated them as high or low probability of being neuroleptic malignant syndrome. RESULTS: Nine of the 19 cases of clozapine-related neuroleptic malignant syndrome and eight of the 13 cases of risperidone-related neuroleptic malignant syndrome were designated as having high probability of being neuroleptic malignant syndrome. The remainder were designated as having low probability because presentations were not linked to treatment or failed to meet criteria for the syndrome. CONCLUSIONS: Neuroleptic malignant syndrome can occur in patients given atypical antipsychotics and resembles "classical" neuroleptic malignant syndrome. However, side effect profiles overlap considerably with neuroleptic malignant syndrome criteria, and atypical antipsychotics may cause neurotoxicities unrelated to (but misattributed as) neuroleptic malignant syndrome. Insufficient evidence exists for "atypical" neuroleptic malignant syndrome with novel antipsychotics. (Am J Psychiatry 1998; 155:1113–1116)
This article has been cited by other articles:
|
|
|
|
 
C. M. Lowe, R. R A. Grube, and A. C Scates
Characterization and Clinical Management of Clozapine-Induced Fever
Ann. Pharmacother.,
October 1, 2007;
41(10):
1700 - 1704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-S. Chungh, B.-N. Kim, and S.-C. Cho
Neuroleptic malignant syndrome due to three atypical antipsychotics in a child
J Psychopharmacol,
July 1, 2005;
19(4):
422 - 425.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. M. Blass and M. Chuen
Olanzapine-Associated Hypothermia
Psychosomatics,
April 1, 2004;
45(2):
135 - 139.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Taylor and M. Fink
Catatonia in Psychiatric Classification: A Home of Its Own
Am J Psychiatry,
July 1, 2003;
160(7):
1233 - 1241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. YANG and M. J. McNEELY
Rhabdomyolysis, Pancreatitis, and Hyperglycemia With Ziprasidone
Am J Psychiatry,
August 1, 2002;
159(8):
1435 - 1435.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. BOURGEOIS, S. BABINE, M. MEYEROVICH, and J. DOYLE
A Case of Neuroleptic Malignant Syndrome With Quetiapine
J Neuropsychiatry Clin Neurosci,
February 1, 2002;
14(1):
87 - 87.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Adnet, P. Lestavel, and R. Krivosic-Horber
Neuroleptic malignant syndrome
Br. J. Anaesth.,
July 1, 2000;
85(1):
129 - 135.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Lee, H.-J. Lee, and L. Kim
A Case of Delayed NMS Induced by Risperidone
Psychiatr Serv,
February 1, 2000;
51
(2):
254 - 255.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. F. BUCKLEY and S. Hasan
Atypical Neuroleptic Malignant Syndrome and Atypical Antipsychotics
Am J Psychiatry,
November 1, 1998;
155(11):
1626l - 1626.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1998
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
